case report a neonate with subcutaneous fat necrosis after...
TRANSCRIPT
Hindawi Publishing CorporationCase Reports in PediatricsVolume 2013, Article ID 254089, 3 pageshttp://dx.doi.org/10.1155/2013/254089
Case ReportA Neonate with Subcutaneous Fat Necrosis afterPassive Cooling: Does Polycythemia Have an Effect?
Erhan Calisici,1 Mehmet Yekta Oncel,1 Halil Degirmencioglu,1,2 Gonca Sandal,3
Fuat Emre Canpolat,1 Omer Erdeve,4 Serife Suna Oguz,1 and Ugur Dilmen1,5
1 Zekai Tahir Burak Maternity Teaching Hospital, Neonatology, 06230 Ankara, Turkey2Division of Neonatology, Zekai Tahir Burak Maternity Teaching Hospital, Cebeci, 06230 Ankara, Turkey3 Department of Pediatrics, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey4Department of Pediatrics, Faculty of Medicine, Ankara University, 06100 Ankara, Turkey5 Department of Pediatrics, Faculty of Medicine, Yildirim Beyazit University, Ankara, Turkey
Correspondence should be addressed to Halil Degirmencioglu; [email protected]
Received 22 May 2013; Accepted 24 June 2013
Academic Editors: J. Kobr and W. B. Moskowitz
Copyright © 2013 Erhan Calisici et al. This is an open access article distributed under the Creative Commons Attribution License,which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Subcutaneous fat necrosis (SCFN) is an inflammatory disorder of adipose tissue. The main risk factors for the development ofSCFN are perinatal asphyxia and hypothermia. Presented here is a case of a newborn who developed SCFN in association withpolycythemia and hypocalcemia following treatment by passive cooling. Neonates who undergo passive or whole body coolingtherapy should be closely monitored for any signs of SCFN.
1. Introduction
Subcutaneous fat necrosis (SCFN) of the newborn is acondition characterized by inflammation of subcutaneous fattissue in term and postterm neonates. The best recognizedrisk factors for the development of SCFN are asphyxiaand hypothermia [1, 2]. The hypoxic conditions created bycold and hypoperfusion trigger the development of granu-lomatous inflammation of subcutaneous fat tissue followedby necrosis. Other predisposing factors include maternaldiabetes, preeclampsia, cocaine abuse or use of calcium chan-nel blockers during pregnancy, birth asphyxia, meconiumaspiration, hypothermia, hypoxemia, and hypoglycemia[1].
Presented here is a case of a newborn who requiredmechanical ventilation immediately after birth due to res-piratory failure thought to have developed as a result ofmeconium aspiration. With a suspicion of birth asphyxia,passive coolingwas performed after which SCFNdeveloped 3days postnatally. To the best of our knowledge, this is the firstreported case of SCFN occurring in association with passivecooling.
2. Case Report
The patient was a girl born to a 30-year-old mother after 40weeks of gestation, delivered by Cesarean section. At birth,she weighed 2500 gr.Themother, who was otherwise healthy,had an uneventful pregnancy. On delivery, the amnioticfluid was heavily stained with thick meconium, and thepatient’s first and fifth minute APGAR scores were 2 and 3,respectively, which prompted intubation and transfer to theneonatal intensive care unit.
On admission, she was hypoactive and hypotonic, mea-suring at 47 cm in length (25–50 p)with a head circumferenceof 33 cm (25–50 p). Results of cord blood gas analysis wereconsistent with mixed acidosis (pH: 7.01; pCO
2; 63.4mmHg;
pO2: 44.9mmHg; HCO
3: 12mmol/L; BE: −12,1mmol/L).The
patient also did not have any signs of encephalopathy, andfindings on amplitude EEG monitorization were normal. Adecision to proceed with passive cooling was made as aprecaution against hypoxic effects on the brain. This wasachieved by first decreasing the set temperature of the incu-bator and leaving its lid open tomaintain a rectal temperatureof 34-35∘C.
2 Case Reports in Pediatrics
Hypoglycemia (40mg/dL), which was encounteredwithin the first few hours after admission, was treated byrapid intravenous infusion of a glucose solution. Bloodsamples obtained 6 hours after admission revealed CRP andIL6 levels of 29.6mg/dL and >1000 ng/mL, respectively, forwhich combination antibiotic therapy with penicillin G andgentamicin was initiated. A hematocrit of 72% also promptedthe patient to be treated with partial blood exchangetransfusion using saline.
Other laboratory results included a serum AST levelof 2110U/L, ALT of 1033U/L, CPK of 3887U/L, LDH of572U/L, BUN of 28.9mg/dL, creatinine of 1.29mg/dL, anduric acid of 7.94mg/dL. On day 2 postnatally, serum calciumlevel was 6.8mg/dL, while other serum electrolytes werewithin normal range. Calcium replacement was achievedwith calcium gluconate. Blood levels of 25-OH vitamin D,ALP, and parathormone were normal.
On the third day postnatally, the patient developed ery-thema and swelling on her back and over the posterior aspectsof her arm, particularly in areas overlying pressure points(Figure 1). A punch biopsy from one of the lesions revealedhistopathological findings consistent with SCFN (Figure 2).The patient’s lesions gradually improved and the patient wassubsequently discharged pending outpatient follow-up.
3. Discussion
SCFN is a benign and mostly self-limited condition whichusually resolves within a week. Despite recent advances,its etiopathogenesis remains elusive. Previous studies haveimplicated perinatal asphyxia, hypothermia, meconium aspi-ration, maternal diabetes mellitus, preeclampsia, sepsis, andbirth trauma as risk factors for the development of SCFN[1]. The stress conditions brought about by these factorsresult in reduced tissue perfusion, and the ensuing hypoxialeads to crystallization of free fatty acids in subcutaneous fattissue, which is soon followed by tissue necrosis [2]. In acase series by Burden and Krafchik, perinatal asphyxia wasthe most frequently encountered etiologic factor among 11patients with SCFN [1]. Several factors may have contributedto the development of SCFN in our patient, includingmeconium aspiration, respiratory failure, polycythemia, andhypoglycemia. Furthermore, passive cooling may have alsobeen a contributory factor.
To the best of our knowledge, SCFN has not beenpreviously reported in association with passive cooling, whileon the other hand a possible association with whole bodycooling has been suggested [3, 4]. In our patient, passivecooling is inmost likelihood not the sole cause responsible forthe development of SCFN, although it may have acceleratedthe pathogenic process in the presence of other underlyingrisk factors.
Skin lesions of SCFN may manifest as early as 72 hours,although lesions developing as late as 6 weeks postnatallyhave also been reported [5]. In our patient, the lesionsmanifested on the third day of admission.
Hypoglycemia is another risk factor that has beenreported in association with SCFN. However, whether it is
Figure 1: Macroscopic appearance of SCFN in our patient.
Figure 2:Microscopic appearance of SCFN showing the presence ofadipocytes with eosinophilic cytoplasms and histiocytes infiltratingbetween them.
a cause or merely a consequence of this condition is stillunknown. Although gestational diabetes is an importantcause of neonatal hypoglycemia, our patient’s mother didnot have diabetes. Furthermore, SCFN has been reported tooccur in the absence of maternal diabetes [6, 7], and as suchit is plausible to suggest that hypoglycemia is a result of thestress posed by hypoxia.
Varan et al. managed to demonstrate that severe anemiain the neonatal period may trigger SCFN by reducing tissueperfusion [8]. Rather than being anemic, our patient hadpolycythemia which required treatment with partial bloodexchange transfusion. We believe that, by affecting tissueperfusion, hypoxia and hypothermia were both primarilyresponsible for the development of SCFN in our patient.We did not encounter a case of SCFN in association withpolycythemia in the literature.
Complications of SCFN include hypercalcemia, pain,dyslipidemia, renal failure, and late subcutaneous atrophy[9]. Despite being a rare complication, hypercalcemia has anegative impact on morbidity and mortality. Research hasshown hypercalcemia to develop as a result of increasedprostaglandin activity, release of calcium from necrotic fattissue, and increased secretion of 1,2-dihydroxy vitamin Dfrom macrophages. Periodic evaluation of serum calciumlevels is therefore recommended in such patients. In con-trast, our patient developed hypocalcemia on the second
Case Reports in Pediatrics 3
day postnatally which required treatment. In a previousreport on hypocalcemia occurring in association with SCFN,pseudohypoparathyroidism was identified as the underlyingcause [10]. In our patient, however, parathormone, 25-OHvitamin D, and ALP levels were normal.
SCFN is a commonly encountered problem in newbornswho suffer hypoxia. Such patientsmostly require follow-up inthe intensive care setting where they are exposed to extensivetherapeutic procedures and invasive interventions. SCFN isalso known to develop on areas overlying pressure points,which highlights the importance of nurse care. Appropriatemobilization and frequent changes in position are among themeasurements that could be implemented to preserve tissueperfusion and therefore decrease the likelihood of a patientdeveloping SCFN.
SCFN is a complication that should come to mind innewborns with birth hypoxia, and the presence of hypother-mia and polycythemiamay accelerate the pathogenic process.In neonates hospitalized for perinatal asphyxia, special careshould be taken to avoid therapeutic hypothermia unlessabsolutely indicated, while also stressing the importance ofnurse care for preventing the development of SCFN.
References
[1] A. D. Burden and B. R. Krafchik, “Subcutaneous fat necrosis ofthe newborn: a review of 11 cases,” Pediatric Dermatology, vol.16, no. 5, pp. 384–387, 1999.
[2] D. A. Katz, C. Huerter, P. Bogard, and S. W. Braddock, “Subcu-taneous fat necrosis of the newborn,” Archives of Dermatology,vol. 120, no. 11, pp. 1517–1518, 1984.
[3] M. Hogeling, K. Meddles, D. R. Berk et al., “Extensive subcuta-neous fat necrosis of the newborn associated with therapeutichypothermia,” Pediatric Dermatology, vol. 29, no. 1, pp. 59–63,2012.
[4] V. Oza, J. Treat, N. Cook, M. T. Tetzlaff, and A. Yan, “Subcu-taneous fat necrosis as a complication of whole-body coolingfor birth asphyxia,” Archives of Dermatology, vol. 146, no. 8, pp.882–885, 2010.
[5] W. P. Walker, R. J. H. Smith, and M. B. Cohen, “Fine-needleaspiration biopsy of subcutaneous fat necrosis of the newborn,”Diagnostic Cytopathology, vol. 9, no. 3, pp. 329–332, 1993.
[6] J. I. Caple and S. Reyes, “Subcutaneous fat necrosis of thenewborn: a case presentation,” Journal of Perinatology, vol. 16,no. 2, pp. 140–141, 1996.
[7] G. Coleman Oswalt Jr., L. F. Montes, and G. Cassady, “Sub-cutaneous fat necrosis of the newborn,” Journal of CutaneousPathology, vol. 5, no. 4, pp. 193–199, 1978.
[8] B. Varan, B. Gurakan, N. Ozbek, and S. Emir, “Subcutaneousfat necrosis of the newborn associated with anemia,” PediatricDermatology, vol. 16, no. 5, pp. 381–383, 1999.
[9] E. Mahe, N. Girszyn, S. Hadj-Rabia, C. Bodemer, D. Hamel-Teillac, and Y. De Prost, “Subcutaneous fat necrosis of thenewborn: a systematic evaluation of risk factors, clinical man-ifestations, complications and outcome of 16 children,” BritishJournal of Dermatology, vol. 156, no. 4, pp. 709–715, 2007.
[10] K. Karochristou, T. Siahanidou, T. Kakourou-Tsivitanidou, K.Stefanaki, and H. Mandyla, “Subcutaneous fat necrosis asso-ciated with severe hypocalcaemia in a neonate,” Journal ofPerinatology, vol. 26, no. 1, pp. 64–66, 2006.
Submit your manuscripts athttp://www.hindawi.com
Stem CellsInternational
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
MEDIATORSINFLAMMATION
of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Behavioural Neurology
EndocrinologyInternational Journal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
BioMed Research International
OncologyJournal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Oxidative Medicine and Cellular Longevity
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
PPAR Research
The Scientific World JournalHindawi Publishing Corporation http://www.hindawi.com Volume 2014
Immunology ResearchHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Journal of
ObesityJournal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Computational and Mathematical Methods in Medicine
OphthalmologyJournal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Diabetes ResearchJournal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Research and TreatmentAIDS
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Gastroenterology Research and Practice
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Parkinson’s Disease
Evidence-Based Complementary and Alternative Medicine
Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com